Paralympic Doctor Returns to Sport as Blind Athlete with Guide Runner
Dr Oscar, a former Paralympic competitor turned medical professional, returns to sport as a blind athlete with specialized guide runner…
Editor's Top Picks
World’s First Rooftop ICU Opens in London to Study Nature’s Role in Patient Recovery
King's College Hospital in London opens the world's first rooftop ICU to study how natural environments affect patient recovery. The…
Submit Your Paper to GMJ
AI Drug Monitoring System Failed to Detect Months of Fentanyl Theft at Tennessee Hospital
AI-powered drug monitoring system Sentri7 failed to detect months of fentanyl theft at a Tennessee hospital, raising concerns about the…
Mobile NHS lung cancer screening detects 10,000 cases in supermarket car parks
NHS mobile lung cancer screening units operating in supermarket car parks have successfully detected 10,000 cases across England. The innovative…
Bananas in Berry Smoothies Cut Antioxidant Absorption by 84%, Study Finds
New research shows bananas can reduce antioxidant absorption from berry smoothies by 84%. The surprising discovery has implications for dietary…
Genetic Trade-off Between Youth and Longevity Discovered in Landmark Study
Scientists identify the vgll3 gene as a key regulator creating a fundamental trade-off between early-life advantages and long-term health. This…
UK Reports Sharp Summer COVID-19 Rise as Hospitalizations Jump 24% in One Week
COVID-19 hospitalizations in England jumped 24% in one week during late June 2026, defying typical summer respiratory illness patterns. UK…
House cats’ cancer genetics reveal new treatment pathways for human breast cancer
A landmark study analyzing 495 cat tumors worldwide revealed 85% genetic similarity with human breast cancer. The research opens new…
Methionine Amino Acid Protects Against Fatal Inflammation in Preclinical Study
Salk Institute research shows methionine amino acid dramatically improved survival in mice with severe inflammatory conditions by enhancing kidney filtration…
Immune Drug Delays Rheumatoid Arthritis by Four Years After Treatment Ends
Clinical trial shows one year of abatacept treatment delayed rheumatoid arthritis onset by up to four years in high-risk individuals.…